lung cancer drug Keytruda

News

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.